$2.00
0.01[0.50%]
Last update: 9:51AM Get Real Time Here
SILO Pharma
(NASDAQ:SILO)Latest News for SILO Pharma Stock (NASDAQ:SILO)
SILO Pharma Stock (NASDAQ: SILO)
Categories: All
Tuesday, April 23, 2024
Wednesday, April 17, 2024
Thursday, April 11, 2024
Wednesday, April 10, 2024
Tuesday, April 09, 2024
Friday, April 05, 2024
Tuesday, April 02, 2024
Saturday, March 30, 2024
Friday, March 29, 2024
Wednesday, March 20, 2024
- Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And MoreLara Goldstein - Mar 20, 2024, 2:49PM
- Silo Pharma Exercises Option For Exclusive License Agreement For First-In-Class PTSD And Stress-Induced Anxiety TherapeuticBenzinga Newsdesk - Mar 20, 2024, 8:32AM
Monday, March 18, 2024
Thursday, March 14, 2024
Monday, March 04, 2024
Wednesday, February 28, 2024
Thursday, February 15, 2024
Wednesday, February 14, 2024
Thursday, February 01, 2024
Saturday, January 27, 2024
Wednesday, January 24, 2024
Friday, January 12, 2024
Monday, January 08, 2024
Thursday, January 04, 2024
- Silo Pharma Concludes First Phase of Dose-Ranging Study Of Intranasal Treatment For Post Traumatic Stress DisorderVandana Singh - Jan 4, 2024, 8:55AM
- Silo Pharma Plans To Submit A Pre-IND Application To The FDA In Q1 2024 Based On Preclinical Data And Collaborative Work With Columbia UniversityBenzinga Newsdesk - Jan 4, 2024, 8:55AM
- Silo Pharma Provided An Update On Its Dose-Ranging Study Of SPC-15, A Targeted Treatment For PTSD, Stating That The Animals In The Study Tolerated The Intranasal Dosing Procedure Well With No Adverse Observations ReportedBenzinga Newsdesk - Jan 4, 2024, 8:55AM
Thursday, December 28, 2023
- Fibromyalgia Care Breakthrough: DEA Green Lights Biotech Partnership Exploring Ketamine Implant TherapyLara Goldstein - Dec 28, 2023, 3:10PM
- Silo Pharma Announced An Update On Its Dosage And Time-Release Ketamine-Loaded Implant, Designated As SP-26, Which Is Being Developed As A Potential At-Home Pain Relief Treatment For Fibromyalgia And Other Chronic Pain ConditionsBenzinga Newsdesk - Dec 28, 2023, 8:26AM
Wednesday, December 27, 2023
Monday, December 18, 2023
Monday, December 11, 2023
Friday, December 08, 2023
Tuesday, December 05, 2023
Friday, November 24, 2023
Thursday, November 23, 2023
Wednesday, November 22, 2023
Tuesday, November 21, 2023
- 12 Health Care Stocks Moving In Tuesday's After-Market SessionBenzinga Insights - Nov 21, 2023, 4:31PM
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga Insights - Nov 21, 2023, 8:06AM
- Silo Pharma Collaborates With Medspray Pharma For Intranasal Technology For Stress Disorder CandidateVandana Singh - Nov 21, 2023, 8:00AM
- Silo Pharma Says 'Exclusivity covers multiple indications including anxiety disorders, Alzheimer's disease, and anorexia'Benzinga Newsdesk - Nov 21, 2023, 8:00AM
- Silo Pharma Enters Into Exclusives License Agreement With Medspray Pharma BV For Intranasal Technology Used In SPC-15 Treatment For PTSDBenzinga Newsdesk - Nov 21, 2023, 7:59AM